Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04928300

Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs

Diaphragmatic Function, Pain Quality & Anti-inflammatory Properties: A Low Dose Dexmedetomidine Versus Ketamine in Patients With Multiple Fracture Ribs Needing Conservative Treatment

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.

Detailed description

A written informed consent from patients or thier legal guardians, Patients will be assigned randomly to two groups (30 subjects each) with traumatic multiple fracture ribs 3 ribs or more. After thoracic epidural is inserted, the drug study intervention will be started and run for 5 days during ICU admission. In (Group D) low dose dexmedetomidine infusion 0.2 µ/kg/hour IV for 5 days. In (Group C) the same dose and duration of normal saline will be given.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidinelow dose dexmedetomidine infusion 0.2 µ/kg/hour IV for 5 days.
OTHER0.9% salinethe same dose and duration of normal saline will be given for 5 days.

Timeline

Start date
2021-06-12
Primary completion
2027-07-01
Completion
2027-07-25
First posted
2021-06-16
Last updated
2026-01-02

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04928300. Inclusion in this directory is not an endorsement.